Japan addresses counterfeit drug issues during quality audits by implementing stringent regulatory frameworks, utilizing advanced technologies like serialization and track-and-trace systems, and conducting thorough inspections. Collaboration with international organizations and continuous training for inspectors further enhance their ability to detect and prevent counterfeit drugs, ensuring the integrity of the pharmaceutical supply chain.